Skip to main content
Fig. 5 | Journal for ImmunoTherapy of Cancer

Fig. 5

From: Targeting interferon signaling and CTLA-4 enhance the therapeutic efficacy of anti-PD-1 immunotherapy in preclinical model of HPV+ oral cancer

Fig. 5

Analysis of immune correlates for combination immunotherapy in the mEER flank-tongue pseudometastasic model. Mice were treated as in Fig. 4a except for ICT antibody administrations performed only on days 10, 13 and 16. Leukocytes isolated from both flank and tongue tumors at day 18 after tumor implantation were analyzed by flow cytometry. Frequencies of total CD8+ T cells, Granzyme B+ CD8+ T cells (CTL), Treg, Arg1+ MDSC as well as ratios of CTL to Treg and Arg1+ MDSC are shown. Results represent pooled data from two experiments (n = 8–14). Statistical significance was calculated using two-way ANOVA and post-hoc correction performed with controlling for false discovery rate (FDR); * < 0.05, ** < 0.01, *** < 0.001

Back to article page